Author(s): Naveen Pemmaraju, Haris Ali, Vikas Gupta EHA Library. Pemmaraju N. Jun 14, 2019; 266467; PF668 Abstract: PF668 Session topic: 16. Myeloproliferative neoplasms – Clinical Background Patients with myelofibrosis (MF) who fail or are intolerant to JAK inhibitors (JAKi) have limited treatment options. Tagraxofusp is a targeted therapy directed to CD123 that...
Pro zobrazení tohoto obsahu je třeba být přihlášen.